Changes In Ctc Burden And Prevalence Of Specific Ctc Subtypes In Mcrpc Patients (Pts) Receiving Alpharadin (Ra-223) As Single Agent Or In Combination With Other Therapuetics (Tx).
JOURNAL OF CLINICAL ONCOLOGY（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要